Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and Efficacy of Once Daily Saquinavir/Ritonavir + Truvada in HIV Pretreated Patients
NCT00476983Phase 3Withdrawn
- Sponsor
- HIV-NAT
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of saquinavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Status: withdrawn.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00476983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476983.